Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Immuneering Corporation (IMRX) had Stock-Based Compensation of $3.22M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-14.43M |
|
-- |
|
-- |
|
$14.76M |
|
$-14.76M |
|
$0.32M |
|
$-14.43M |
|
$-14.43M |
|
$-14.43M |
|
$-14.43M |
|
$-14.43M |
|
$-14.43M |
|
$-14.76M |
|
$-14.58M |
|
35.99M |
|
35.99M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$27.73M |
|
$0.96M |
|
$12.33M |
|
$40.06M |
|
$7.49M |
|
-- |
|
$3.63M |
|
$11.12M |
|
$28.94M |
|
$21.91M |
|
$28.94M |
|
35.99M |
|
| Cash Flow Statement Financials | |
$-23.53M |
|
$-0.01M |
|
$13.75M |
|
$36.14M |
|
$26.36M |
|
$-9.79M |
|
|
Stock-Based Compensation |
$3.22M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-49.88% |
|
-65.88% |
|
-36.03% |
|
-49.88% |
|
$0.80 |
|
$-0.65 |
|
$-0.65 |
|